Results 81 to 90 of about 11,221 (162)

Epidemiology of Pertussis After the COVID-19 Pandemic: Analysis of the Factors Involved in the Resurgence of the Disease in High-, Middle-, and Low-Income Countries

Vaccines
Pertussis is a highly contagious bacterial disease of the respiratory tract that can be prevented by vaccination. Before the COVID-19 pandemic, the vaccine coverage rate for the third dose of a DPT-containing vaccine was 86%, with large disparities among
Lucia F. Bricks, Juan C. Vargas-Zambrano, Denis Macina   +2 more
doaj   +1 more source

Understanding the High Incidence of Pertussis in Norway: The Role of Test Activity

Acta Paediatrica, EarlyView.
Margrethe Greve‐Isdahl, Elina Seppälä   +1 more
wiley   +1 more source

A Protocol of National Mixed‐Methods Assessment of Childhood and Maternal Immunization

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Background and Aims Accurate measurement of routine immunization coverage is essential for detecting immunity gaps, guiding programmatic responses, and supporting equitable vaccine delivery. Iran's Expanded Programme on Immunization has achieved high coverage, but administrative estimates can mask some disparities.
Seyed Aria Nejadghaderi, Paria Dehesh, Mehran Nakhaeizadeh, Mohammadreza Rajabalipour, Faeze Tahrudi, Naser Nasiri, Seyed Mohsen Zahraei, Hamid Sharifi, AliAkbar Haghdoost   +8 more
wiley   +1 more source

Short‐Term Safety and Adverse Event Risk Profiles for SARS‐CoV‐2 Booster Vaccine Doses in Australian Adults: A Survey Study

Medical Journal of Australia, Volume 224, Issue 6, June 2026.
ABSTRACT Objective This study quantifies the short‐term risk profiles of seven severe acute respiratory syndrome coronavirus 2 virus (SARS‐CoV‐2) vaccines—Comirnaty Bivalent BA.1, Comirnaty Bivalent BA.4‐5, Comirnaty XBB.1.5, Spikevax Bivalent BA.1, Spikevax Bivalent BA.4‐5, Spikevax XBB.1.5 and Nuvaxovid—administered as booster doses in Australia ...
Evelyn Tay, Michael Dymock, Lucy Dawes, Lucy Deng, Thuy Nguyen, Alan Leeb, Julie A. Marsh, Nicholas Wood, Kristine Macartney, Thomas L. Snelling   +9 more
wiley   +1 more source

IS481-based pertussis positivity transition from preschool to school-aged children and the ptxP3 predominance in high-load subset: a digital platform surveillance study in China

Emerging Microbes and Infections
China experienced a massive pertussis resurgence in 2024. We aimed to characterize the epidemiological trends, clinical symptoms, and molecular evolution of Bordetella pertussis using a large-scale, home-based surveillance platform in four Chinese ...
Chunyan Xiang, Zichen Lei, Tingting You, Ziyi Chu, Dong Liu, Jinghan Huang, You Li, Binghuai Lu, Bin Cao, Yeming Wang   +9 more
doaj   +1 more source

Higher uptake of common adult vaccines in Australian blood donors: An analysis of linked registry data

Vox Sanguinis, Volume 121, Issue 5, Page 570-580, May 2026.
Abstract Background and Objectives Understanding differences in blood donor vaccine uptake is essential for accurately interpreting serosurveillance of vaccine‐preventable diseases and other research using donor samples and/or data. We aimed to assess vaccination uptake in donors and non‐donors.
Surendra Karki, Veronica Hoad, Bette Liu, Marijke Welvaert, Rena Hirani, David O. Irving   +5 more
wiley   +1 more source

EPIDEMIOLOGICAL CHARACTERISTICS OF PERTUSSIS IN PCR TESTED PATIENTS WITH SUSPECTED INFECTION [PDF]

Journal of IMAB
Purpose: To analyze epidemiological and clinical data of individuals tested for pertussis within the framework of routine disease surveillance Material and Methods: We conducted a retrospective analysis of epidemiological and clinical characteristics in
Milena Karcheva, Cvetan Popov, Polya Marinovska, Georgi Golemanov, Nelly Doseva, Maria Sredkova   +5 more
doaj   +1 more source

Paediatric surveillance of pertussis in 1998

, 2000
Objective: To gain insight into the severity of pertussis in hospitalised cases. Methods: In 1998, hospitalisation data were collected through paediatric surveillance. Results: From 115 hospitalisation admissions collected, 55% of the patients were younger than 3 months of age and not vaccinated; 12% were 3-5 months of age and of these, 50% were ...
Melker HE de, Neppelenbroek SN, Schellekens JFP, Suijkerbuijk AWM, Conyn- van Spaendonck MAE   +4 more
openaire   +1 more source

The Senegal pertussis trial: safety and surveillance of adverse reactions.

Developments in biological standardization, 1997
In the Senegal pertussis trial, common adverse reactions were actively monitored during the pilot phase II study, while the frequency of severe adverse reactions was monitored as a secondary objective within the phase III efficacy trial. Since the trial was conducted in Niakhar, an area in rural West Africa under intensive surveillance, the safety ...
Préziosi, Marie-Pierre, Ndiaye, Malick, Coll-Seck, A., Simondon, François   +3 more
openaire   +2 more sources

Genomic surveillance reveals global spread of macrolide-resistant Bordetella pertussis linked to vaccine changes

Journal of Clinical Microbiology
The resurgence of whooping cough in regions utilizing acellular pertussis vaccines underscores emerging public health challenges. Here, we characterized 178 Bordetella pertussis isolates collected from patients across all age groups in Shanghai (2018 ...
Zhen Xu, Zhuoying Huang, Lingyue Yuan, Huanyu Wu, Xin Chen, Min Chen, Yuan Zhuang, Jun Feng   +7 more
doaj   +1 more source